TiE Announces AI Driven Lantern Pharma as 2018 Top 50 Emerging Company
Published: May 01, 2018
TiE Inflect (previously TiEcon) is the world's largest conference for entrepreneurs and intrapreneurs with participation from top technology companies, leading venture capital firms, and global services providers. TiEcon 2017 attracted 5400+ attendees from across the world - including CEOs of established companies to first-time entrepreneurs creating new companies, to leading investment professionals and corporate executives. The conference was listed by Worth Magazine as one of the 10 best conferences for ideas and entrepreneurship along with TED and the World Economic Forum. For more information, please visit http://www.tieinflect.org.
The Indus Entrepreneurs (TiE) is a not-for-profit founded in 1992 in the Silicon Valley by a group of successful entrepreneurs, corporate executives, and senior professionals. TiE is the world's largest network of tech entrepreneurs. We are a cohesive global network with a footprint of half million entrepreneurs, enterprise executives, investment professionals, and other accomplished individuals. We operate from 60 cities in 16 countries. http://www.tieeco.org.
About Lantern Pharma Inc
Lantern Pharma is a late clinical stage precision oncology company that is using proprietary AI tech platform to identify drug specific genetic signatures (potential CDX) for patient stratification with a high prediction accuracy for focused precision clinical trials. RADR is integrating clinical data, with data generated from wet-lab approach closely modeling real world evidence/clinical trials and machine learning to identify genetic signatures and potential responders to the drug. Lantern's approach can improve success of the drug, lower developmental costs and time many folds vs traditional drug developmental processes.
Source: Lantern Pharma